Chinook Therapeutics (KDNY) Files Mixed Shelf
Tweet
Share
E-mailGet Alerts KDNY Hot Sheet
Up)Join SI Premium – FREE
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Chinook Therapeutics (NASDAQ: KDNY) has filed mixed shelf of: Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chinook Therapeutics (KDNY) Receives Orphan Drug Designation from European Commission for BION-1301 for Treatment of Primary IgA Nephropathy
- Noah Holdings (NOAH) Prices 1.1M Share Global Offering at $18.60/ADS
- Chinook Therapeutics Receives Orphan Drug Designation from European Commission for BION-1301 for Treatment of Primary IgA Nephropathy (IgAN)
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
